- Home
- XGN vs SGMO Comparison
XGN vs SGMO Comparison
Compare XGN & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- SGMO
- Stock Information
- Founded
- XGN 2002
- SGMO 1995
- Country
- XGN United States
- SGMO United States
- Employees
- XGN N/A
- SGMO N/A
- Industry
- XGN Medical Specialities
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XGN Health Care
- SGMO Health Care
- Exchange
- XGN Nasdaq
- SGMO Nasdaq
- Market Cap
- XGN 138.3M
- SGMO 122.8M
- IPO Year
- XGN 2019
- SGMO 2000
- Fundamental
- Price
- XGN $9.74
- SGMO $0.50
- Analyst Decision
- XGN Strong Buy
- SGMO Strong Buy
- Analyst Count
- XGN 5
- SGMO 7
- Target Price
- XGN $12.40
- SGMO $5.29
- AVG Volume (30 Days)
- XGN 217.1K
- SGMO 4.5M
- Earning Date
- XGN 11-11-2025
- SGMO 11-11-2025
- Dividend Yield
- XGN N/A
- SGMO N/A
- EPS Growth
- XGN N/A
- SGMO N/A
- EPS
- XGN N/A
- SGMO N/A
- Revenue
- XGN $58,862,000.00
- SGMO $81,706,000.00
- Revenue This Year
- XGN $22.09
- SGMO $21.24
- Revenue Next Year
- XGN $13.62
- SGMO N/A
- P/E Ratio
- XGN N/A
- SGMO N/A
- Revenue Growth
- XGN 3.89
- SGMO 565.52
- 52 Week Low
- XGN $2.38
- SGMO $0.41
- 52 Week High
- XGN $10.34
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- XGN 56.30
- SGMO 43.36
- Support Level
- XGN $9.55
- SGMO $0.51
- Resistance Level
- XGN $10.28
- SGMO $0.56
- Average True Range (ATR)
- XGN 0.37
- SGMO 0.03
- MACD
- XGN -0.08
- SGMO -0.00
- Stochastic Oscillator
- XGN 34.94
- SGMO 29.08
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.